Stay updated on Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page's revision history was updated to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange Detected- Added Revision: v3.4.2 and removed the temporary government funding lapse notice.SummaryDifference0.5%

- Check42 days agoChange DetectedAdded a government funding/NIH operating status notice and updated the site to revision 3.4.1 (replacing 3.4.0).SummaryDifference0.5%

- Check49 days agoChange DetectedAdded a glossary toggle and updated page metadata, including a new 'Last Update Submitted that Met QC Criteria' label and revision note to v3.4.0. The older 'Last Update Submitted that met QC Criteria' label, the 'No FEAR Act data' entry, and the old 'Revision: v3.3.4' were removed.SummaryDifference0.3%

- Check63 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded a site revision note: Revision: v3.3.3. Removed the HHS Vulnerability Disclosure and the previous revision note Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page.